Carmel, IN, —Geni Inc. has begun a series of pharmacokinetic studies on WokVel™, their Boswellia Serrata Extract. The compulsory study will offer valuable information regarding the pharmacological effects of Boswellia Serrata extract in the body. The data will determine the optimum dose, dosing schedule, correlate plasma concentrations with observed beneficial effects, look for adverse drug reactions, and examine toxicity levels.
The much anticipated results can be expected in late September. Geni Inc. manufactures Ayurvedic herbal extracts with an uncompromised commitment to providing significant scientific data relating to their products.
Geni’s next study, currently in the protocol stage, will be examing the effects of a proprietary formulation in the management of Diabetes. For more information, please contact our office at 317.587.8818 or visit www.geniherbs.com.